Jim Simons Longboard Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$18.89 - $26.06 $1.35 Million - $1.86 Million
71,400 New
71,400 $1.54 Million
Q2 2023

Aug 11, 2023
BUY
$4.19 - $10.05 $65,783 - $157,785
15,700 New
15,700 $115,000
Q3 2021

Nov 12, 2021
SELL
$8.65 - $11.36 $89,960 - $118,144
-10,400 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$7.95 - $17.3 $82,680 - $179,920
10,400 New
10,400 $95,000

Others Institutions Holding LBPH

# of Institutions
101
Shares Held
32.5M
Call Options Held
28.9K
Put Options Held
13.9K
View Full List

About Longboard Pharmaceuticals, Inc.

LBPH Quotes by TradingView
  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $815M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email